Response by Wiberg et al to Letter Regarding Article, "Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial"

Circulation. 2017 May 16;135(20):e1044-e1045. doi: 10.1161/CIRCULATIONAHA.117.027774.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Exenatide*
  • Glucagon-Like Peptide 1*
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Neuroprotective Agents
  • Out-of-Hospital Cardiac Arrest

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Neuroprotective Agents
  • Glucagon-Like Peptide 1
  • Exenatide